Key result
Primary stenting for aortoiliac occlusive disease resulted in a 24-month primary patency rate of 93% for simple lesions compared to 63% for complex lesions.
Why the study?
The study evaluated midterm outcomes and influencing factors of primary iliac artery stenting, comparing results between patients with simple versus complex aortoiliac occlusive disease.
Does primary stenting yield different midterm patency rates in simple versus complex aortoiliac occlusive disease?
Observational (n=93)
No
Does primary stenting yield different midterm patency rates in simple versus complex aortoiliac occlusive disease?
Absolute Event Rate: 93% vs 63%
p-value: p=<0.001
Primary stenting for aortoiliac occlusive disease provides high technical success and acceptable midterm patency, though outcomes are significantly better for simple compared to complex lesions.
Introduction The purpose of this study was to report the midterm outcomes of primary stenting of iliac arteries with additional factors which affect the outcome and to compare the results between patients with simple and complex aorta iliac occlusive disease (AOID). Material and methods From January 2015 and March 2018, the study consisted of 103 lesions in 93 patients with common iliac artery (CIA) and/or external iliac artery (EIA) lesions which accompanied with severe claudication or critical limb ischemia. Balloon-expandable stents (BMS), self-expandable stents (SES) and covered stents (CS) were used to treat the lesions. Results Lesions of 93 patients that were in CIA and/or EIA and treated with ET were included to the study (n=103). Seventy-one (68.9%) lesions were classified as simple AIOD group (TASCII A-B) while 32(31.1%) were classified as complex AIOD (TASCII C-D) group. In 72.8% of the lesions only mild calcification was detected while 27.2% lesions had moderate or severe calcification. Mean stent diameter for CIA position was 8.26±0.8mm and for EIA position was 7.52±0.8mm. Mean lesion length in patients treated with BMS were 52.5±21.0mm while SES were 63.6±28.3(p=0.03). Technical success was achieved in 101(98.1%) lesions. Significant differences in primary (93% vs 63%) and secondary (98% vs 82%) patency rates at 24 months were found between patients in simple and complex AIOD group (p<0.001 p=0.001) Conclusions Conclusion: In our study, it was found that the primary stenting in patients who had AIOD had satisfactory results with high immediate success, low complication rates and acceptable midterm outcomes.
No takes yet. Share an insight, caveat, or question.
Atay et al. (2021) conducted an observational in Aortoiliac occlusive disease (n=93). Primary stenting for simple AIOD (TASC II A-B) vs. Primary stenting for complex AIOD (TASC II C-D) was evaluated on Primary patency at 24 months (p=<0.001). Primary stenting for aortoiliac occlusive disease resulted in a 24-month primary patency rate of 93% for simple lesions compared to 63% for complex lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: